Rehmann Capital Advisory Group Acquires 2,768 Shares of Aetna Inc (AET)

Share on StockTwits

Rehmann Capital Advisory Group increased its holdings in shares of Aetna Inc (NYSE:AET) by 144.2% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 4,687 shares of the company’s stock after acquiring an additional 2,768 shares during the quarter. Rehmann Capital Advisory Group’s holdings in Aetna were worth $860,000 at the end of the most recent reporting period.

Other large investors have also recently bought and sold shares of the company. Cornerstone Advisors Inc. lifted its holdings in shares of Aetna by 263.6% in the 1st quarter. Cornerstone Advisors Inc. now owns 600 shares of the company’s stock worth $101,000 after acquiring an additional 435 shares during the last quarter. Bruderman Asset Management LLC purchased a new stake in Aetna during the 1st quarter worth approximately $118,000. Kaizen Advisory LLC increased its stake in Aetna by 143.9% during the 2nd quarter. Kaizen Advisory LLC now owns 766 shares of the company’s stock worth $141,000 after buying an additional 452 shares during the period. Clearwater Capital Advisors LLC purchased a new stake in Aetna during the 1st quarter worth approximately $154,000. Finally, CSat Investment Advisory L.P. purchased a new stake in Aetna during the 2nd quarter worth approximately $162,000. Institutional investors own 83.49% of the company’s stock.

NYSE:AET traded up $2.06 during trading hours on Friday, reaching $201.01. 1,918,126 shares of the company’s stock were exchanged, compared to its average volume of 2,164,633. Aetna Inc has a 1-year low of $149.69 and a 1-year high of $206.66. The stock has a market cap of $66.41 billion, a P/E ratio of 20.39, a P/E/G ratio of 1.74 and a beta of 0.69. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.74 and a quick ratio of 0.74.

Aetna (NYSE:AET) last released its earnings results on Thursday, August 2nd. The company reported $3.43 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $3.04 by $0.39. The company had revenue of $15.56 billion during the quarter, compared to analysts’ expectations of $15.59 billion. Aetna had a net margin of 5.77% and a return on equity of 20.66%. The business’s revenue was up .2% on a year-over-year basis. During the same quarter last year, the business earned $3.42 EPS. Sell-side analysts expect that Aetna Inc will post 11.31 EPS for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Thursday, November 1st. Stockholders of record on Wednesday, October 24th will be issued a $0.50 dividend. The ex-dividend date of this dividend is Tuesday, October 23rd. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.99%. Aetna’s dividend payout ratio is presently 20.28%.

AET has been the topic of several recent research reports. ValuEngine raised shares of Aetna from a “hold” rating to a “buy” rating in a research report on Tuesday, June 26th. Zacks Investment Research downgraded shares of Aetna from a “hold” rating to a “sell” rating in a research report on Tuesday, July 24th. Finally, Cantor Fitzgerald reaffirmed a “buy” rating and issued a $202.00 target price on shares of Aetna in a research report on Thursday, August 2nd. Eight investment analysts have rated the stock with a hold rating and six have issued a buy rating to the company. Aetna presently has an average rating of “Hold” and an average price target of $203.77.

Aetna Profile

Aetna Inc operates as a health care benefits company in the United States. It operates through three segments: Health Care, Group Insurance, and Large Case Pensions. The Health Care segment offers medical, pharmacy benefit management service, dental, behavioral health, and vision plans on an insured and employer-funded basis.

Recommended Story: Compound Annual Growth Rate (CAGR)

Institutional Ownership by Quarter for Aetna (NYSE:AET)

Receive News & Ratings for Aetna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna and related companies with's FREE daily email newsletter.

Leave a Reply